UBS Group
FCSC

UBS Group’s Fibrocell Science Inc. FCSC Stock Holding History

UBS Group’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,253
Closed -$19K – 8710
2019
Q3 		$19K Sell
6,253
-1,286
-17% -$2.64K ﹤0.01% 6787
2019
Q2 		$14K Buy
+7,539
New +$15.4K ﹤0.01% 6881
2019
Q1 		– Sell
-4,372
Closed -$7K – 8477
2018
Q4 		$7K Sell
4,372
-2,641
-38% -$5.28K ﹤0.01% 7449
2018
Q3 		$17K Buy
7,013
+5,644
+412% +$12.2K ﹤0.01% 6905
2018
Q2 		$4K Buy
1,369
+1,362
+19,457% +$3.94K ﹤0.01% 7596
2018
Q1 		$0 Sell
7
-4,520
-100% -$14.8K ﹤0.01% 8392
2017
Q4 		$14K Buy
4,527
+4,520
+64,571% +$39.5K ﹤0.01% 6834
2017
Q3 		$0 Sell
7
-434
-98% -$7.02K ﹤0.01% 8169
2017
Q2 		$9K Buy
+441
New +$5.44K ﹤0.01% 6870
2016
Q4 		– Sell
-400
Closed -$4K – 8208
2016
Q3 		$4K Buy
+400
New +$5.93K ﹤0.01% 7230
2015
Q4 		– Sell
-33
Closed -$2K – 8696
2015
Q3 		$2K Sell
33
-141
-81% -$12.5K ﹤0.01% 8127
2015
Q2 		$14K Buy
+174
New +$11.7K ﹤0.01% 7213

UBS Group's FCSC Position: Q4 2019 in Review

UBS Group sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 6,253 shares — an estimated $19K sold.

UBS Group first reported a position in FCSC in Q2 2015 and held it in 12 quarters. The position peaked at $19K in Q3 2019. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.

  • UBS Group reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
  • UBS Group sold 6,253 Fibrocell Science Inc. shares in Q4 2019, an estimated $19K.
  • UBS Group first reported a position in Fibrocell Science Inc. in Q2 2015 and held it in 12 quarters.
  • UBS Group's Fibrocell Science Inc. position peaked at $19K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.